Jaguar Health, Inc. (NASDAQ:JAGX - Get Free Report)'s stock price gapped down prior to trading on Thursday . The stock had previously closed at $7.69, but opened at $7.02. Jaguar Health shares last traded at $5.94, with a volume of 295,622 shares traded.
Analyst Upgrades and Downgrades
Separately, StockNews.com began coverage on shares of Jaguar Health in a research note on Thursday, May 16th. They set a "sell" rating on the stock.
Check Out Our Latest Stock Analysis on JAGX
Jaguar Health Stock Performance
The company has a debt-to-equity ratio of 1.84, a quick ratio of 1.39 and a current ratio of 1.89. The firm has a 50-day moving average price of $9.60 and a 200-day moving average price of $10.02.
Jaguar Health (NASDAQ:JAGX - Get Free Report) last issued its quarterly earnings results on Tuesday, May 14th. The biotechnology company reported ($3.60) EPS for the quarter. Jaguar Health had a negative return on equity of 642.15% and a negative net margin of 377.95%. The business had revenue of $2.35 million during the quarter. As a group, research analysts expect that Jaguar Health, Inc. will post -0.09 earnings per share for the current year.
About Jaguar Health
(
Get Free Report)
Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.
Featured Articles
Before you consider Jaguar Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Jaguar Health wasn't on the list.
While Jaguar Health currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
